Godavari Biorefineries rallies after securing European patent for anti-cancer compounds

Attention Investors

Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000. | Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors." | KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." | ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

- EQUITY
  EQUITY
  PRICE
  
  Gainers & Losers
  
  Advances & Declines
  
  New Highs & Lows
  
  Index Movers
  
  Only Buyers/Sellers
  
  Out/Under Performers
- NEWS
  CORPORATE ACTIONS
  
  Announcements
  
  Book Closure
  
  Board Meetings
  
  Bonus Issues
  
  Rights Issues
  
  De-Listed Shares
  
  Market Turnover
  
  Change of Name
  
  Split of Face Value
- OTHER MARKETS
  FII Investments
  
  MF Investments
  
  ADR Prices
  
  World Indices
  
  Forex
  
  CORPORATE INFO
- VOLUME
  VOLUME
  Value & Volume Toppers
  
  Unusual Volume
  
  Bulk & Block Deals
  
  Sector Watch
- ANALYSIS
  ANALYSIS
  52 Week High Low
  
  Live Indices
  
  Exchange Holidays
  
  Index Constituents
  
  Historical Returns
  
  Circuit Breakers
- IPO
  IPO
  
  Forthcoming Issues
  
  Open Issues
  
  Closed Issues
  
  New Listing
  
  Basis of Allotment
  
  Draft Prospectus
  
  New Issue Monitor
  
  Best Performers
  
  Know IPO's / FAQ's

24 December 2025 00:00:00

Adani Ports

1494.65

(0.06%)

Asian Paints

2785.50

(-0.81%)

Axis Bank

1226.70

(0.16%)

Bajaj Finance

1014.85

(0.34%)

Bajaj Finserv

2035.85

(-0.56%)

Bharat Electro..

400.05

(0.18%)

Bharti Airtel

2123.75

(0.06%)

Eternal

284.80

(0.14%)

HCL Technologi..

1674.90

(-0.24%)

HDFC Bank

997.10

(0.07%)

Hind. Unilever

2282.90

(-0.80%)

ICICI Bank

1359.50

(-0.26%)

Infosys

1662.40

(-0.34%)

Interglobe Avi..

5078.55

(-1.48%)

ITC

406.65

(-0.25%)

Kotak Mah. Ban..

2164.45

(0.12%)

Larsen & Toubr..

4052.80

(-0.16%)

M & M

3637.60

(0.35%)

Maruti Suzuki

16707.90

(0.79%)

NTPC

322.60

(-0.19%)

Power Grid Cor..

268.15

(0.45%)

Reliance Indus..

1557.95

(-0.82%)

SBI

969.00

(-0.29%)

Sun Pharma.Ind..

1737.50

(-1.01%)

Tata Steel

170.00

(-0.53%)

TCS

3320.35

(0.30%)

Tech Mahindra

1631.10

(-0.06%)

Titan Company

3908.50

(-0.36%)

Trent

4288.90

(2.36%)

UltraTech Cem.

11760.55

(0.73%)

	Equity Analysis

	News Analysis

	Corporate Actions

	Other Market

	Company Profile

Share Holding Pattern

Your results on : Equity | News | Company-News

Godavari Biorefineries rallies after securing European patent for anti-cancer compounds	Share Back
(16 Oct 2025)
The patent, filed under its anti-cancer research segment, covers new chemical compounds that target cancer stem cells. These compounds have shown strong potential in treating cancers such as breast and prostate. The development strengthens the company’s research portfolio and marks a step forward in its efforts toward high-value therapeutic innovation. Godavari Biorefineries is a leading integrated biorefinery specializing in bio-based chemicals, ethanol, and sugar & power production. The company one of the larger producers of ethanol and a pioneer in manufacturing ethanol-based chemicals in India. The company operates cutting-edge facilities in Sakarwadi, Maharashtra, and Sameerwadi, Karnataka and three advanced R&D facilities in Mumbai and plant locations. On a consolidated basis, Godavari Biorefineries reported net loss of Rs 16.02 crore in Q1 June 2025 as against net loss of Rs 26.11 crore in Q1 June 2024. Net sales rose 2.05% YoY to Rs 533.24 crore in Q1 June 2025.
Top